# Morgenthaler Ventures

> Morgenthaler Ventures is a VC fund backing Health Care and Biotechnology. See 228 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Menlo Park, United States
- Total investments: 228
- Last investment: Aug 2025
- Lead investor: 15%
- Fund size: $400M
- Last fund: Nov 2008
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/morgenthaler/about/
- X (Twitter): http://twitter.com/Morgenthaler_V
- Website: http://www.morgenthaler.com

Morgenthaler Ventures is a VC fund in Menlo Park focused on Health Care and Biotechnology. Morgenthaler Ventures has been in the venture capital business for more than 45 years, steadily investing through every market cycle. Select past and present portfolio companies in the IT space include: Evernote, Lending Club, Siri, MuleSoft, Practice Fusion, Adara Media, Check, Doximity, PeopleMatter, Socrata, NuoDB, Jaspersoft, VoltageSecurity, Rhythm NewMedia, Nominum, Wize Commerce (NexTag) and back in the day, Apple.

## Contacts

5 contacts available for Morgenthaler Ventures. Shizune tracks 16 team members at Morgenthaler Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/morgenthaler-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 40 | 18% |
| Biotechnology | 29 | 13% |
| Medical | 25 | 11% |
| Medical Device | 20 | 9% |
| Software | 19 | 8% |

118 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 50 | 22% |
| Series A | 41 | 18% |
| Funding Round | 38 | 17% |
| Series C | 37 | 16% |
| Series D | 23 | 10% |

13 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 108 | 47% |
| Canada | 1 | 0% |
| France | 1 | 0% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Bob Pavey | Partner | 14 | https://shizune.co/investors/profile/bob-pavey |
| Hank Plain | Partner | 20 | https://shizune.co/investors/profile/hank-plain |
| Bridget Odorcic | Operations & Fund Compliance Manager | 0 | https://shizune.co/investors/profile/bridget-odorcic |
| Ching Wu | VP of Investor Relations & Marketing | 0 | https://shizune.co/investors/profile/ching-wu |
| Gary Little | Partner | 47 | https://shizune.co/investors/profile/gary-little |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SetPoint Medical | SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $115M | Series D | Aug 11, 2025 |  |
| Moximed | Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis. | $61M | Series D | Aug 13, 2024 |  |
| Relievant Medsystems | Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain. | $50M | Series G | Mar 27, 2023 |  |
| SetPoint Medical | SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $80M |  | Jan 19, 2023 |  |
| SetPoint Medical | SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $80M | Series C | Jan 19, 2023 |  |
| Moximed | Moximed Inc. is dedicated to improving the standard of care for patients with osteoarthritis, and is investigating therapies to treat a number of affected joints. The lead product, the KineSpring® Knee Implant System, is designed for patients with knee osteoarthritis. | $40M | Series C | Aug 16, 2022 |  |
| SetPoint Medical | SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $64M |  | Jan 27, 2021 |  |
| SetPoint Medical | SetPoint Medical is a company that developed a device-based therapeutic approach for treating rheumatoid arthritis. The company's product, the SetPoint System, is a small, wireless implantable device that stimulates the vagus nerve to reduce inflammation. The therapy is an approach for adults with active rheumatoid arthritis who have notresponded to other treatments. | $64M | Series B | Jan 27, 2021 |  |
| Relievant Medsystems | Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain. | $70M |  | Oct 29, 2020 |  |
| Relievant Medsystems | Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain. | $70M | Series F | Oct 29, 2020 |  |

10 of 228 investments shown.

## Co-investors
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 23 deals together
- [Hummer Winblad Venture Partners](https://shizune.co/investors/profile/hummer-winblad-venture-partners) — VC Fund, 20 deals together
- [Advanced Technology Ventures](https://shizune.co/investors/profile/advanced-technology-ventures) — VC Fund, 14 deals together
- [Canaan Partners](https://shizune.co/investors/profile/canaan-partners) — VC Fund, 14 deals together
- [Split Rock Partners](https://shizune.co/investors/profile/split-rock-partners) — VC Fund, 14 deals together
- [Domain Associates](https://shizune.co/investors/profile/domain-associates) — VC Fund, 10 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Medical VC Funds in United States](https://shizune.co/investors/medical-vc-funds-united-states)
- [Manufacturing VC Funds in United States](https://shizune.co/investors/manufacturing-vc-funds-united-states)
- [Medical Device Investors in United States](https://shizune.co/investors/medical-device-investors-united-states)
- [Medical Device VC Funds in United States](https://shizune.co/investors/medical-device-vc-funds-united-states)

## FAQ

### What does Morgenthaler Ventures invest in?

Morgenthaler Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series A stage. Most of the 228 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Morgenthaler Ventures?

Public channels for Morgenthaler Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Morgenthaler Ventures?

The team at Morgenthaler Ventures includes Bob Pavey (Partner), Hank Plain (Partner) and Bridget Odorcic (Operations & Fund Compliance Manager), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co